Template:Dehydroemetine: Difference between revisions

Jump to navigation Jump to search
(Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969...")
 
mNo edit summary
 
Line 1: Line 1:
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
| style="padding: 0 5px; font-size: 100%; background:#696969" align=center | <span style="color:WHITE;"> '''[[Dehydroemetine|Dehydroemetine]]'''</span>
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Dehydroemetine|{{fontcolor|#6C7B8B|Dehydroemetine}}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:WHITE" align=left | FDA Package Insert (Mebadin<sup>®</sup>)
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | MEBADIN<sup>®</sup> Prescribing Information
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine general information|General Information]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine clinical information|Clinical Information]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine microbiology|Microbiology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine dosage and administration|Dosage and Administration]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine indications and usage|Indications and Usage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine contraindications|Contraindications]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine warnings|Warnings]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine precautions|Precautions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine precautions|Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine use in pregnancy|Use in Pregnancy]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine clinical studies|Clinical Studies]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine dosage and administration|Dosage and Administration]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine adverse effects|Adverse Effects]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine how supplied|How Supplied]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine drug interactions|Drug Interactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Dehydroemetine storage|Storage]]
|-
|-
|}
|}

Latest revision as of 00:26, 31 December 2013